ALLK Allakos Inc: Rasio nilai perusahaan marang pendapatan

Allakos Therapeutics (ALLK) - logo korporat

The erosion of Allakos Inc. (ALLK) competitive advantages due to test failures has diminished confidence in their platform. On GURU.Markets, the company's price-to-sales trajectory visualizes this decline, where determines the latest valuation metric. While steady demand for immunotherapy offsets macroeconomic headwinds, geopolitics creates risks for supply chains and patent protection.

Allakos Inc. (ALLK) - Multiplikator EV/Sales saka 04.07.2022 nganti 20.11.2026

ALLK (Allakos Therapeutics): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:
- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:ALLK (Allakos Inc.)
Produk seri Allakos Inc

To verify the credit quality of Allakos Inc. (ALLK), analysts utilize the EV/Sales ratio, which compares the total enterprise value to annual sales, eliminating the impact of debt load on capitalization. The stable operation of R&D laboratories and the pristine condition of equipment confirm production potential, allowing investors to use this chart to determine the fairness of the market premium for the company's technological innovations.

Pesaing langsung

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Multiplikator nilai perusahaan marang pendapatan Protagonist Therapeutics PTGX|Nilai perusahaan marang pendapatan IMVT (Immunovant Therapeutics)|Rasio total nilai perusahaan marang pendapatan kiniksa.com|Rasio nilai perusahaan marang pendapatan Grifols Biemat GRFS|Koefisien nilai perusahaan marang pendapatan ADPT (Adaptive Biotechnologies Corporation)|celldex.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Aurinia Pharma AUPH|biocryst.com (BCRX) - Rasio nilai perusahaan marang pendapatan|Vera Therapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Dianthus Therapeutics Inc|Pharvaris NV (PHVS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABCL|Tourmaline Corp - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales PGEN (precigen.com)|Rasio nilai perusahaan marang dodolan pharming.com|NKTR - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Upstream Bio Corp|ZBIO: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Immunome, Inc.|Nilai perusahaan marang pendapatan GOSS|KALV: Nilai bisnis marang pendapatan|Multiplikator EV/Sales SEPN|Nilai perusahaan marang pendapatan Pieris Pharmaceuticals, Inc. PVLA|Multiplikator EV/Sales SVRA (Savara Inc)|Multiplikator EV/Sales Rigel Pharmaceuticals RIGL|AnaptysBio Inc. - Multiplikator EV/Sales|Astria Therapeutics - Koefisien nilai perusahaan marang pendapatan|ENGN: Multiplikator EV/Sales|RAPT - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan JBIO|Aclaris (ACRS) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales KYTX|Nilai perusahaan marang pendapatan Tiziana Life Sciences TLSA|Multiplikator EV/Sales CABA (cabalettabio.com)|Koefisien nilai perusahaan marang pendapatan VTYX (Ventyx Bio)|Theratechnologies, Inc - Multiplikator EV/Sales|AVTX (Avalo Therapeutics Inc.) - Rasio nilai perusahaan marang pendapatan|eledon.com (ELDN) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AGEN|CLYM (climbbio.com) - Multiplikator EV/Sales|Multiplikator EV/Sales zurabio.com|Rasio nilai perusahaan marang pendapatan aTyr (ATYR)|ADAG - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ImageneBio Inc IMA|Multiplikator EV/Sales Shattuck Labs, Inc. STTK|EQ - Rasio nilai perusahaan marang pendapatan|connectbiopharm.com (CNTB) - Nilai perusahaan marang pendapatan|IMUX (Immunic) - Nilai perusahaan marang pendapatan|Atara Biotherapeutics, Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan InflaRx|Nilai perusahaan marang pendapatan x4pharma.com (XFOR)|Multiplikator EV/Sales ACET|Nilai perusahaan marang pendapatan Celularity Corp CELU|INmune Bio Inc - Nilai perusahaan marang pendapatan|BRNS (Barinthus Bio) - Nilai perusahaan marang volume dodolan|KZR - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan sabbiotherapeutics.com SABS|Akari Therapeutics PLC (AKTX) - Rasio nilai perusahaan marang pendapatan|ENLV - Rasio total nilai perusahaan marang pendapatan|QTTB (Q32 Bio) - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan GeoVax Labs Inc GOVX|Rasio nilai perusahaan marang pendapatan Edesa Biotech (EDSA)|Nilai perusahaan marang pendapatan iBio IBIO|Carisma Therapeutics Inc - Nilai perusahaan marang pendapatan|XTLB - Nilai perusahaan marang pendapatan|BOLT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan HCWB (hcwbiologics.com)|APVO: Multiplikator EV/Sales|aimimmuno.com (AIM) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan aditxt.com|Nilai perusahaan marang pendapatan GRI Bio Corp (GRI)|Rasio nilai perusahaan marang pendapatan XORTX Therapeutics Inc. (XRTX)|Nilai perusahaan marang pendapatan ReShape Lifesciences HIND|Rasio nilai perusahaan marang pendapatan Revelation Biosciences REVB|INDP: Rasio nilai perusahaan marang pendapatan|SCNI - Rasio nilai perusahaan marang pendapatan|CALI (calcimedica.com) - Rasio nilai perusahaan marang pendapatan|AFMD (Affimed Therapeutics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD